MNRO
MONRO, INC.
Next earnings Jul 28, 2026 · consensus $0.02 EPS, $293M rev
Last earnings -2.1% on 2026-05-27
$17.21
▲ +1.47%$17.21▲ +24.77%
over 1Y
L $12.29H $23.10
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.5%
1W+7.2%
1M+9.1%
3M+9.8%
YTD-9.9%
1Y+24.8%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy
Cheap on sales and a fat ~7% dividend, but a shrinking, barely-profitable turnaround — own it, don't chase it.
Revenue $1.16B · FY2026
The read
Middling fundamentals and a rich price (~94% above fair value) leave little margin of safety — a wait-and-see.
Monro is a classic melting-turnaround setup. Revenue has declined every year from $1.36B (FY2022) to $1.16B (FY2026, -3.2% YoY), and profitability has been gutted: net income fell from $61.6M in FY2022 to a $5.18M loss in FY2025 before a barely-positive $2.17M in FY2026. Net margin is 0.2%, operating margin 1.7%, and ROE 0.4% — the FY2026 P/E of 573.7 is meaningless because the 'E' is near zero. The bull case is entirely valuation and self-help: at 0.4x sales the market is pricing in continued decline, while the business still throws off $70.4M of operating cash flow.
The filing confirms this is an actively-managed restructuring, not a healthy compounder. The Board installed a turnaround CEO (Peter Fitzsimmons, formerly of AlixPartners) and closed 145 underperforming stores under the May 2025 Store Closure Plan, taking $14.8M of closing costs but also harvesting real value — $19.7M net proceeds and a $9.9M gain on 26 owned-store sales, plus $12.2M of gains from lease assignments/terminations. Operating income rose 59.4% to $20.0M off that pruning. The Nov 2025 limited-duration shareholder rights plan (poison pill, 17.5% trigger) strongly signals someone is accumulating shares — meaning takeover/activist optionality is a live, un-modeled catalyst.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 12:38 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Financials · annual, by fiscal year
| Line item | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | $1.36B | $1.33B | $1.28B | $1.20B | $1.16B |
| Gross profit | $482M | $456M | $452M | $418M | $405M |
| Operating income | $101M | $79.8M | $71.4M | $12.6M | $20.0M |
| Net income | $61.6M | $39.0M | $37.6M | -$5.18M | $2.17M |
| Diluted EPS | $1.81 | $1.20 | $1.18 | -$0.22 | $0.03 |
| Net margin | 4.5% | 2.9% | 2.9% | -0.4% | 0.2% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$562M
EV / EBITDA6.9
EV / Sales0.5
EV / FCF14.5
P / FCF13.3
PEG (trailing)4.04
Earnings yield0.4%
FCF yield7.5%
Quality & risk
ROIC (est.)2.4%
Free cash flow$38.8M
Total debt$60.0M
Net cash-$45.4M
Altman Z-Score1.40 distress
Piotroski F-Score6/9
Capital returns
Buyback yield8.5%
Dividend yield (est.)6.8%
Shareholder yield15.3%
Shares Δ YoY+0.2%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
- DEF 14A Proxy statement2026-07-02
Annual proxy: director slate and say-on-pay for a turnaround year with near-zero EPS
- 8-K Other event2026-06-16
Item 8.01 other-events disclosure; no material financial change signaled for shareholders
- 8-K Earnings results2026-05-27
FY2026 revenue $1.16B (-3.2%), net income $2.2M positive; 145 stores closed, EPS $0.03
- 10-K Annual report2026-05-27
FY2026 revenue $1.16B (-3.2%), net income $2.2M positive; 145 stores closed, EPS $0.03
- 8-K Other event2026-02-13
Item 8.01 other-events notice; routine disclosure with no earnings or guidance change
- 8-K Earnings results2026-01-28
Q3 FY2026: sales still declining but cost actions supporting return to profitability
- 10-Q Quarterly report2026-01-28
Q3 FY2026: sales still declining but cost actions supporting return to profitability
- 8-K Officer / director change2025-12-04
Fitzsimmons named permanent CEO and joins Board, ending AlixPartners interim setup
- 8-K Other event2025-11-19
Adopted 1-yr limited-duration shareholder rights plan (poison pill) at 17.5% trigger
Recent filings
all on EDGAR ↗ARSPeriod ending 2026-03-282026-07-02open ↗DEFA14AFiling2026-07-02open ↗DEF 14APeriod ending 2026-08-112026-07-02open ↗11-KPeriod ending 2025-12-312026-06-29open ↗4Period ending 2026-06-182026-06-23open ↗4Period ending 2026-06-132026-06-23open ↗4Period ending 2026-06-132026-06-23open ↗4Period ending 2026-06-132026-06-23open ↗4Period ending 2026-06-132026-06-23open ↗4Period ending 2026-06-132026-06-23open ↗8-KPeriod ending 2026-06-162026-06-16open ↗10-KPeriod ending 2026-03-282026-05-27open ↗
Frequently asked
- Is MONRO, INC. (MNRO) a buy?
- MNRO currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Cheap on sales and a fat ~7% dividend, but a shrinking, barely-profitable turnaround — own it, don't chase it.
- What is MNRO's fair value?
- A Modified-Graham model based on MNRO's SEC fundamentals estimates a fair value of about $1.06. It is an estimate from reported earnings, not a price target.
- Is MNRO overvalued or undervalued?
- Against a Modified-Graham fair-value estimate, MNRO currently appears overvalued relative to its SEC-grounded earnings power.
- What is MONRO, INC.'s quality score?
- MNRO scores 58.28520607260403/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0000876427, latest 10-K filed 2026-05-27) · EODHD · Proprietary analysis · as of 7/3/2026, 4:38:38 AM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.